Buy
Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials
Susan J. Tofte FNP (Assistant Professor),Kim Papp MD, PhD (Founder and President),Neil Sadick MD (Professor),Krista Bohnert BS (Director of Research),Eric Simpson MD, MCR (Professor),Diamant Thaçi MD, PhD (Professor),Thomas Bieber MD, PhD, MDRA (Professor),Andrew Blauvelt MD, MBA (President),Howard Sofen MD (Associate Clinical Professor),Melinda Gooderham MD (Medical Director),Zhen Chen PhD (Sr. Manager),Abhijit Gadkari PhD (Director, Global HEOR),Laurent Eckert PhD (Director, Global HEOR),Neil M. H. Graham MD, MPH, MBBS (VP Program Direction),Gianluca Pirozzi MD, PhD (VP Global),Marius Ardeleanu MD (Senior Director Clinical Sciences)